(Q64217291)
Statements
A Phase II Trial Evaluating the Use of a Histone Deacetylase Inhibitor Panobinostat for Graft Versus Host Disease (GVHD) Prevention (English)
0 references
23 February 2016
0 references
December 2019
0 references
64
0 references
18 year
0 references